HADV (Health Advance) Research & Development: $0.00 Mil (TTM As of Sep. 2017)


What is Health Advance Research & Development?

Health Advance HADV Research & Development is $0.00 Mil as of Sep. 2017.

Research & Development is the aggregate amount of research and development expenses during the year. Health Advance's Research & Development for the three months ended in Sep. 2017 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2017 was $0.00 Mil.

Health Advance  (OTCPK:HADV) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Health Advance Research & Development Related Terms

Health Advance Research & Development Historical Data

* Premium members only.

The historical data trend for Health Advance's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Health Advance Research & Development Chart

Health Advance Annual Data
Trend Jul11 Jul12 Jul13 Jul14 Jul15
Research & Development
0.00 0.00 0.00 0.00 0.00

Health Advance Quarterly Data
Oct12 Jan13 Apr13 Jul13 Oct13 Jan14 Apr14 Jul14 Oct14 Jan15 Apr15 Jul15 Oct15 Jan16 Apr16 Jul16 Oct16 Jan17 Apr17 Sep17
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Health Advance Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.00 Mil mean?
Health Advance (HADV) has a Research & Development of $0.00 Mil as of Sep. 2017. Research and development expense is the total cost for research and development activities. View historical data on Health Advance and its competitors.
Is Health Advance's Research & Development too high?
Health Advance's current Research & Development is $0.00 Mil.
How does Health Advance's Research & Development compare to MYDP and HEWA?
Health Advance's Research & Development of $0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Health Advance and its competitors. Health Advance's current Research & Development is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Health Advance stock overvalued right now?
Health Advance (HADV) has a current Research & Development of $0.00 Mil. The current Research & Development is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Health Advance (HADV), the current Research & Development is $0.00 Mil as of Sep. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Health Advance Business Description

Address 9131 Keele Street, Suite A4, Vaughan, ON, CAN, L4K 0G7
Health Advance Inc is engaged in the retail domain. The Company is focused on products that are oriented to health and wellness. The first example of this is a proprietary CBD-infused wine beverage. The company is in the analysis stage for Immune boosting nutraceuticals, and human wellness products.